回顾性分析提示固定ARR阈值可能低估年轻高血压患者的原发性醛固酮增多症
Potential under-recognition of primary aldosteronism in young adults with hypertension
一项纳入14750例高血压患者的回顾性分析显示,在确诊原发性醛固酮增多症的患者中,基线ARR低于20的比例随年龄降低而升高,<35岁组为57.5%,≥55岁组为33.2%。
- Article
- Published: 12 October 2026
- Jianwen Zhao1 na1,
- Delian Zhang1 na1,
- Junli Hu1,
- Qing Zhu1,
- Jing Hong1,
- Saimire Anwaier1,
- Qin Luo1 &
- …
- Nanfang Li ORCID: orcid.org/0000-0003-1505-85661
Journal of Human Hypertension (2026) Cite this article
Abstract
The aldosterone-to-renin ratio (ARR) is the primary screening test for primary aldosteronism (PA), but it is strongly influenced by renin activity, which varies with age. Fixed ARR thresholds may therefore under-recognize PA in younger adults. We retrospectively analyzed 14,750 hypertensive patients who underwent saline infusion testing for suspected PA. An ARR of 20 was consistently used as the local reference threshold, but confirmatory testing could proceed despite ARR < 20 when clinical suspicion was high. Baseline plasma renin activity (PRA), aldosterone concentration (ALD), and ARR were measured before saline infusion. Of 13,428 patients with calculable ARR, 8703 (64.8%) underwent saline infusion testing despite ARR < 20, and 1578 had confirmed PA. Among 3966 confirmed PA patients with classifiable age-ARR data, ARR < 20 occurred in 57.5, 50.6, 35.4, and 33.2% of patients aged <35, 35–44, 45–54, and ≥55 years, respectively. Increasing age remained associated with lower odds of ARR < 20 after adjustment for sex, body mass index, blood pressure, potassium, creatinine, and a documented adrenal nodule (adjusted OR per year, 0.975; 95% CI, 0.967–0.984). The gradient persisted after restricting analyses to patients without a documented adrenal nodule, with potassium ≥3.5 mmol/L and eGFR ≥60 mL/min/1.73 m². Younger adults with confirmed PA frequently had baseline ARR values below 20, largely with relatively preserved PRA. Although residual referral bias cannot be excluded, these findings support cautious, age-informed interpretation of ALD, PRA, and ARR.
This is a preview of subscription content, access via your institution
Access options
Access through your institution
Subscribe to this journal
Receive 12 digital issues and online access to articles
111,21 € per year
only 9,27 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
39,95 €
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Data availability
The individual-level data used in this study are currently not publicly available due to ethical restrictions on sharing participant data.
References
Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018 ;6:41–50. https://doi.org/10.1016/s2213-8587(17)30319-4
Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021 ;9:876–92. https://doi.org/10.1016/s2213-8587(21)00210-2
Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, et al. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med. 2020 ;173:10–20. https://doi.org/10.7326/M20-0065
Wannachalee T, Lieberman L, Turcu AF. High prevalence of autonomous aldosterone production in hypertension: how to identify and treat it. Curr Hypertens Rep. 2022 ;24:123–32. https://doi.org/10.1007/s11906-022-01176-7
Adler GK, Stowasser M, Correa RR, Khan N, Kline G, McGowan MJ, et al. Primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2025 ;110:2453–95. https://doi.org/10.1210/clinem/dgaf284
Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016 ;101:1889–916. https://doi.org/10.1210/jc.2015-4061
Jaffe G, Gray Z, Krishnan G, Stedman M, Zheng Y, Han J, et al. Screening rates for primary aldosteronism in resistant hypertension: A Cohort Study. Hypertension. 2020 ;75:650–9. https://doi.org/10.1161/hypertensionaha.119.14359
Zekarias K, Tessier KM. Screening rate for primary aldosteronism among patients with apparent treatment-resistant hypertension: retrospective analysis of current practice. Endocr Pract. 2022 ;28:271–5. https://doi.org/10.1016/j.eprac.2021.11.085
Kao TW, Chen JY, Liu JH, Tseng WH, Hsieh CC, Wu VC, et al. Diagnostic efficacy of aldosterone-to-renin ratio to screen primary aldosteronism in hypertension: a systemic review and meta-analysis. Ther Adv Endocrinol Metab. 2024 ;15:20420188241303429. https://doi.org/10.1177/20420188241303429
Stowasser M, Ahmed AH, Pimenta E, Taylor PJ, Gordon RD. Factors affecting the aldosterone/renin ratio. Horm Metab Res. 2012 ;44:170–6. https://doi.org/10.1055/s-0031-1295460
Bauer JH. Age-related changes in the renin-aldosterone system. physiological effects and clinical implications. Drugs Aging. 1993 ;3:238–45. https://doi.org/10.2165/00002512-199303030-00005
Belmin J, Lévy BI, Michel JB. Changes in the renin-angiotensin-aldosterone axis in later life. Drugs Aging. 1994 ;5:391–400. https://doi.org/10.2165/00002512-199405050-00007
Zhang C, Guo Z, Yi C, Wang H, Zhang W, Zhao Y. Age- and sex-specific reference intervals for renin and aldosterone in healthy individuals in Yunnan Province, China. J Hum Hypertens. 2025 ;39:652–7. https://doi.org/10.1038/s41371-025-01006-8
Veldhuizen GP, Alnazer RM, Kroon AA, de Leeuw PW. Variability of aldosterone, renin and the aldosterone-to-renin ratio in hypertensive patients without primary aldosteronism. J Hypertens. 2022 ;40:2256–62. https://doi.org/10.1097/hjh.0000000000003257
Nakama C, Kamide K, Kawai T, Hongyo K, Ito N, Onishi M, et al. The influence of aging on the diagnosis of primary aldosteronism. Hypertension Res. 2014 ;37:1062–7. https://doi.org/10.1038/hr.2014.129
Nwia SM, Leite APO, Li XC, Zhuo JL. Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases. Front Cardiovasc Med. 2023 ;10:1198090. https://doi.org/10.3389/fcvm.2023.1198090
de Freminville JB, Gardini M, Cremer A, Camelli S, Baron S, Bobrie G, et al. Prevalence and risk factors for secondary hypertension in young adults. Hypertension. 2024 ;81:2340–9. https://doi.org/10.1161/hypertensionaha.124.22753
Jehpsson L, Sun J, Nilsson PM, Edsfeldt A, Swärd P. Serum renin levels increase with age in boys resulting in higher renin levels in young men compared to young women, and soluble angiotensin-converting enzyme 2 correlates with renin and body mass index. Front Physiol. 2020 ;11:622179. https://doi.org/10.3389/fphys.2020.622179
Ng E, Gwini SM, Libianto R, Choy KW, Lu ZX, Shen J, et al. Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism. J Clin Endocrinol Metab. 2022 ;108:33–41. https://doi.org/10.1210/clinem/dgac568
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 ;39:3021–104. https://doi.org/10.1093/eurheartj/ehy339
Funding
This study was funded by the Major Science and Technology Projects of Xinjiang Uygur Autonomous Region (2022A03012-5).
Author information
Author notes
These authors contributed equally: Jianwen Zhao, Delian Zhang.
Authors and Affiliations
Hypertension Center of People’s Hospital of Xinjiang Uygur Autonomous Region; Xinjiang Hypertension Institute; NHC Key Laboratory of Hypertension Clinical Research; Key Laboratory of Xinjiang Uygur Autonomous Region “Hypertension Research Laboratory”; Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China
Jianwen Zhao, Delian Zhang, Junli Hu, Qing Zhu, Jing Hong, Saimire Anwaier, Qin Luo & Nanfang Li
Authors
- Jianwen Zhao
- Delian Zhang
- Junli Hu
- Qing Zhu
- Jing Hong
- Saimire Anwaier
- Qin Luo
- Nanfang Li
Contributions
Jianwen Zhao and Delian Zhang drafted the manuscript. Jianwen Zhao and Qin Luo performed the statistical analyses. Junli Hu extracted clinical data and curated the dataset; Qing Zhu reviewed clinical records and validated the data; Jing Hong collected laboratory data and processed samples; and Saimire Anwaier collected clinical data and verified the dataset. Nanfang Li acquired funding and supervised the study.
Corresponding author
Correspondence to Nanfang Li.
Ethics declarations
Competing interests
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethics approval and consent to participate
The study was approved by the Ethics Committee of the People’s Hospital of Xinjiang Uygur Autonomous Region (approval no. KY2026092901). All participants provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Consent for publication Not applicable. No identifiable images or individual participant details are included.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhao, J., Zhang, D., Hu, J. et al. Potential under-recognition of primary aldosteronism in young adults with hypertension. J Hum Hypertens (2026). https://doi.org/10.1038/s41371-026-01245-3
Received: 24 May 2026
Revised: 16 September 2026
Accepted: 06 October 2026
Published: 12 October 2026
Version of record: 12 October 2026
DOI: https://doi.org/10.1038/s41371-026-01245-3
来源:Nature 健康护理主题 · nature.com